Routine Appendicectomy is Unnecessary in Mucinous Borderline Ovarian Tumors

被引：3
|
作者：
Muglu, Javaid [1 ]
Casey, Laura [2 ]
Rather, Henna [3 ]
Makhija, Saloni [2 ]
Brockbank, Elly [1 ]
Kokka, Fani [4 ]
Faruqi, Asma [2 ]
Singh, Naveena [2 ]
Jeyarajah, Arjun [1 ]
机构：
[1] Royal London Hosp, Dept Gynaecol Oncol, London, England
[2] Royal London Hosp, Dept Cellular Pathol, London, England
[3] North Middlesex Univ Hosp, Dept Obstet & Gynaecol, Margate, England
[4] QEQM Hosp, East Kent Gynaecol Oncol Ctr, Margate, England
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY | 2018年 / 37卷 / 01期
关键词：
PSEUDOMYXOMA PERITONEI; INTESTINAL-TYPE; NEOPLASMS; CARCINOMAS; TERATOMAS; APPENDIX; SURGERY;
D O I：
10.1097/PGP.0000000000000372
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：57 / 58
页数：2
相关论文
共 50 条
  • [31] A multiinstitutional consensus study on the pathologic diagnosis of ovarian mucinous borderline tumors and adenocarcinomas
    Chun, Y.
    Chang, E.
    Kim, M.
    Kwon, S.
    Park, M.
    Suh, K.
    Yoon, H.
    Hwang, T.
    An, H.
    Park, J.
    Hong, S.
    Jun, S.
    Kim, I
    [J]. VIRCHOWS ARCHIV, 2009, 455 : 12 - 13
  • [32] Serous and mucinous borderline ovarian tumors: are there real differences between these two entities?
    Benito, Virginia
    Lubrano, Amina
    Arencibia, Octavio
    Medina, Norberto
    Alvarez Eva, Elisa
    Andujar, Miguel
    Falcon Juan, Miguel
    Falcon, Orlando
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2010, 153 (02) : 188 - 192
  • [33] Mucinous borderline ovarian tumors: pathological and prognostic study at Salah Azaiez Institute
    Sahraoui, Ghada
    Fitouri, Asma
    Charfi, Lamia
    Driss, Maha
    Slimane, Maher
    Hechiche, Monia
    Mrad, Karima
    Doghri, Raoudha
    [J]. PAN AFRICAN MEDICAL JOURNAL, 2022, 41 : 349
  • [34] IMMUNOHISTOCHEMICAL EXPRESSION OF ESTROGEN-RECEPTORS IN OVARIAN SEROUS AND MUCINOUS BORDERLINE TUMORS
    JACOBS, TW
    CANNISTRA, S
    NILOFF, J
    ABUJAWDEH, GM
    [J]. LABORATORY INVESTIGATION, 1995, 72 (01) : A91 - A91
  • [35] MUCINOUS BORDERLINE OVARIAN TUMORS: ANALYSIS OF 75 PATIENTS FROM A SINGLE CENTER
    Comert, D. Kavak
    Ureyen, I.
    Karalok, A.
    Tasci, T.
    Turkmen, O.
    Basaran, D.
    Turan, T.
    Tulunay, G.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 568 - 568
  • [36] Ovarian Intestinal Type Mucinous Borderline Tumors: Are We Ready for a Nomenclature Change?
    Chiesa, Andres G.
    Deavers, Michael T.
    Veras, Emanuela
    Silva, Elvio G.
    Gershenson, David
    Malpica, Anais
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2010, 29 (02) : 108 - 112
  • [37] Clinical and ultrasound features of benign, borderline, and malignant invasive mucinous ovarian tumors
    Pascual, A.
    Guerriero, S.
    Rams, N.
    Juez, L.
    Ajossa, S.
    Graupera, B.
    Hereter, L.
    Cappai, A.
    Pero, M.
    Perniciano, M.
    Errasti, T.
    Parra, J.
    Solis, M.
    Alcazar, J. L.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (03) : 382 - 386
  • [38] Mucinous borderline ovarian tumors: Analysis of 75 patients from a single center
    Comert, Duygu Kavak
    Ureyen, Isin
    Karalok, Alper
    Tasci, Tolga
    Turkmen, Osman
    Ocalan, Reyhan
    Turan, Taner
    Tulunay, Gokhan
    [J]. JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2016, 17 (02) : 96 - 100
  • [39] Comparison of tumor markers and clinicopathological features in serous and mucinous borderline ovarian tumors
    Alanbay, I.
    Akturk, E.
    Coksuer, H.
    Ercan, C. M.
    Karasahin, E.
    Dede, M.
    Yenen, M. C.
    Ozan, H.
    Dilek, S.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2012, 33 (01) : 25 - 30
  • [40] DISCREPANCIES BETWEEN FROZEN AND FINAL DIAGNOSIS IN THE EVALUATION OF MUCINOUS BORDERLINE OVARIAN TUMORS
    Sahraoui, Ghada
    Bouhani, Malek
    Fitouri, Asma
    Charfi, Lamia
    Jellali, Amani
    Sakhri, Saida
    Slimane, Maher
    Hechiche, Monia
    Mrad, Karima
    Doghri, Raoudha
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A143 - A144
12345